A person holds an experimental vaccine against the AIDS virus in Shoshaguve, near Pretoria, on November 30, 2016 as South Africa launched a major clinical trial of the experimental vaccine, which scientists hope could be the "final nail in the coffin" for the disease. | Mujahid Safodien/AFP/Getty Images

Engineered Antibodies Block HIV Infection in Primates for 6 Months

In the absence of an HIV vaccine, a single injection of engineered antibodies could block new infections in at-risk populations for months at a time.

Published On 04/17/2018
3:13 PM EDT

Bnabs (Broadly Neutralizing Antibodies) from HIV Vaccine Trials Network on Vimeo.